Hilmi Ataseven Selected Research

DuP 697

1/2016

Effects of a Multikinase Inhibitor Motesanib (AMG 706) Alone and Combined with the Selective DuP-697 COX-2 Inhibitor on Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hilmi Ataseven Research Topics

Disease

2	COVID-19 11/2021 - 10/2020
2	Arthritis (Polyarthritis) 01/2015 - 01/2011
2	Ulcerative Colitis 01/2014 - 01/2011
2	Inflammation (Inflammations) 01/2014 - 03/2010
2	Infections 01/2013 - 03/2010
2	Fibrosis (Cirrhosis) 01/2013 - 06/2009
2	Neoplasms (Cancer) 01/2009 - 07/2006
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Craniocerebral Trauma (Head Injury) 01/2015
1	Mental Disorders (Mental Disorder) 01/2015
1	Stroke (Strokes) 01/2015
1	Cerebral Palsy (Spastic Diplegia) 01/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2015
1	Multiple Sclerosis 01/2015
1	Autistic Disorder (Autism) 01/2015
1	Colitis 01/2014
1	Hepatitis B 01/2013
1	Chronic Hepatitis B 01/2013
1	Crohn Disease (Crohn's Disease) 01/2011
1	Erythema Nodosum 01/2011
1	Pyoderma Gangrenosum 01/2011
1	Diabetes Mellitus 10/2010
1	Mucormycosis 10/2010
1	Insulin Resistance 03/2010
1	Hepatocellular Carcinoma (Hepatoma) 02/2010
1	Diverticulum 06/2009
1	Disease Progression 06/2009
1	Klatskin Tumor 06/2009
1	Liver Diseases (Liver Disease) 06/2009
1	Cholangiocarcinoma 06/2009
1	Pathologic Constriction (Stenosis) 06/2009
1	Cholangitis 06/2009
1	Carcinoma (Carcinomatosis) 01/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2009
1	Hemorrhage 01/2008
1	Peptic Ulcer (Peptic Ulcers) 01/2008
1	Zenker Diverticulum (Zenker's Diverticulum) 07/2006
1	Ulcer 07/2006
1	Tuberculosis (Tuberculoses) 08/2003
1	Weight Loss (Weight Reduction) 08/2003

Drug/Important Bio-Agent (IBA)

1	favipiravirIBA 11/2021
1	Proton Pump InhibitorsIBA 10/2020
1	Pharmaceutical PreparationsIBA 10/2020
1	motesanib diphosphateIBA 01/2016
1	DuP 697IBA 01/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016
1	strontium chloride (strontium chloride Sr 89)FDA LinkGeneric 01/2014
1	Prednisolone (Predate)FDA LinkGeneric 01/2014
1	Tenofovir (Viread)FDA Link 01/2013
1	entecavir FDA Link 01/2013
1	Lamivudine (Epivir)FDA Link 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2013
1	N-isobutylidenedipivalamideIBA 01/2011
1	HDL CholesterolIBA 03/2010
1	LDL CholesterolIBA 03/2010
1	CholesterolIBA 03/2010
1	oxidized low density lipoproteinIBA 03/2010
1	Triglycerides (Triacylglycerol)IBA 03/2010
1	C-Reactive ProteinIBA 03/2010
1	LipidsIBA 03/2010
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2010
1	Tumor Biomarkers (Tumor Markers)IBA 01/2009
1	AntigensIBA 01/2009
1	Pantoprazole (Protonix)FDA LinkGeneric 01/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2006
1	LeptinIBA 08/2003

Therapy/Procedure

5	Therapeutics 01/2014 - 01/2008
2	Stents 06/2009 - 06/2009
1	Equine-Assisted Therapy 01/2015
1	Liver Transplantation 06/2009
1	Operative Surgical Procedures 07/2006
1	Endoscopes 07/2006
1	Aftercare (After-Treatment) 08/2003